Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Albuquerque, New Mexico 87102


Purpose:

The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then they are randomly assigned to receive one of three eight-week follow-up treatments: phone calls from a project therapist, group therapy, or a customized schedule of therapist visits with the adolescent, the adolescent's family and teachers, coaches, probation officers and others who can help the adolescent reach or maintain abstinence. Families are assessed using questionnaires and interviews before, during and after treatment, to provide information about family functioning, the adolescent's drug use, the adolescent's peers and other factors that may contribute to treatment success or failure. Adolescents also provide urine specimens for drug screening at assessment visits. Study investigators expect the study will show that a functional family environment and insulating adolescents from the influence of peers who use drugs will help prevent relapse for adolescents who have received family therapy.


Criteria:

Inclusion Criteria: 1. At least one parent, step-parent, or surrogate parent willing to participate in the study 2. 13 to 18 years if age 3. meets DSM-IV (APA, 1994) diagnostic criteria for substance abuse or dependence 4. Lives in the Albuquerque metropolitan area or surrounding communities with a parent, step-parent, or surrogate parent; AND 5. Sufficient residential stability to permit probable contact at follow-up (e.g., not homeless at time of intake). Exclusion Criteria: 1. Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures 2. Adolescent deemed dangerous to self or others during evaluation 3. Services other than outpatient treatment required for the adolescent (e.g., inpatient, detoxification) 4. Adolescent already has participated in treatment project at CFAR; AND 5. A sibling is already participating in project.


NCT ID:

NCT00680381


Primary Contact:

Principal Investigator
Holly B. Waldron, Ph.D.
Oregon Research Institute Center for Family and Adolescent Research (ORI/CFAR)


Backup Contact:

N/A


Location Contact:

Albuquerque, New Mexico 87102
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 17, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.